Polymer chemistry has been one of the main disruptive forces in the last few decades, having a profound impact on materials used in all applications, enabling new technologies and profoundly impacting everyone’s life. Polymers are at the core of modern material science and despite having generated some concerning environmental challenges, it’s hard to imagine a future without them. 

Dr. Leibfarth is one of the most creative minds in polymer chemistry today and he is leading some incredible innovation in the way these materials are made and applied. He shares a fascinating story of elite collegiate American football, science, inspiration and creativity, as well as where different disciplines converge and provide the disruptive force to change paradigms. 

Paolo and Frank discuss stereo-controlled polymerization, novel functionalization, exploration of structure-function relationships, as well as Frank's personal and professional growth.


We read every email so please share your questions and feedback with us! 

Email [email protected]

 

About Your Host

Paolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy.  He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo’s career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides.

 

He is currently the Director of Global Market Development in the Laboratory Chemicals Division  at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you’ll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he’ll call himself a “maker” at heart.